NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637953. A total of 4 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 300 | -96.2% | 0.00% | – |
| Q4 2021 | $5,000 | -75.0% | 7,900 | -51.8% | 0.00% | – |
| Q3 2021 | $20,000 | -20.0% | 16,400 | -12.3% | 0.00% | – |
| Q2 2021 | $25,000 | +525.0% | 18,700 | +713.0% | 0.00% | – |
| Q1 2021 | $4,000 | -20.0% | 2,300 | +4.5% | 0.00% | – |
| Q4 2020 | $5,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 120 | $29,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 2,200 | $5,000 | 0.00% |
| SIMPLEX TRADING, LLC | 307 | $73,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |